Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04449198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1

Study acronym: T-St1M
StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 1, 2025 to Jan 1, 2027
    • Study completion date: Jul 1, 2025 to Jul 1, 2027
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Primary completion date: Jan 1, 2023 to Jan 1, 2025
    • Study completion date: Jul 1, 2023 to Jul 1, 2025
    v4
  4. Primary completion date: Jan 1, 2022 to Jan 1, 2023
    • Study completion date: Jan 1, 2023 to Jul 1, 2023
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2020 to Oct 14, 2020
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Augusta University
25 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 1 Diabetes
886 trials monitored
See 40 trials at risk
The proposed study is designed to test the hypothesis that treatment of resveratrol for 12 weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial function (aim 2) in people with type 1 diabetes.
Trial Details
NCT Number NCT04449198
Lead Sponsor Augusta University
Conditions
(from sponsor)		 Type 1 Diabetes
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 1, Heart Diseases
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov